Processa Pharmaceuticals (PCSA) announces the appointment of Russell Skibsted as Chief Financial Officer, CFO, effective immediately. Skibsted succeeds James Stanker, who is retiring and staying on in an advisory role to assist in the transition. Most recently, Skibsted served as Senior Vice President and CFO of Alimera Sciences (ALIM).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCSA:
- Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer
- Processa announces results from preliminary eval of Phase 1b trial with NGC-Cap
- Processa Pharmaceuticals files $50M mixed securities shelf